# A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning.

> clinical trial · VERIFIED · 2026-07-31

Status: NOT_YET_RECRUITING · Sponsor: Boston Scientific Corporation · Condition: Hepatocellular Carcinoma (HCC)

- Company: Boston Scientific Corporation
- Sector: Hepatocellular Carcinoma (HCC)
- Primary source: https://clinicaltrials.gov/study/NCT07669727

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.